BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9509502)

  • 1. Multiple drug resistance mediated by P-glycoprotein is not a major factor in a slow response to therapy in childhood ALL.
    Kanerva J; Tiirikainen M; Mäkipernaa A; Riikonen P; Möttönen M; Salmi TT; Krusius T; Saarinen-Pihkala UM
    Pediatr Hematol Oncol; 1998; 15(1):11-21. PubMed ID: 9509502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current results of studies of immunophenotype-, age- and leukocyte-based therapy for children with acute lymphoblastic leukemia. The Pediatric Oncology Group.
    Crist W; Shuster J; Look T; Borowitz M; Behm F; Bowman P; Frankel L; Pullen J; Krance R; Steuber P
    Leukemia; 1992; 6 Suppl 2():162-6. PubMed ID: 1578922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of day 14 blast percentage and the absolute blast index in bone marrow of children with acute lymphoblastic leukemia.
    Visser JH; Wessels G; Hesseling PB; Louw I; Oberholster E; Mansvelt EP
    Pediatr Hematol Oncol; 2001; 18(3):187-91. PubMed ID: 11293286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia.
    Dibenedetto SP; Lo Nigro L; Mayer SP; Rovera G; Schilirò G
    Blood; 1997 Aug; 90(3):1226-32. PubMed ID: 9242556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Griffin TC; Shuster JJ; Buchanan GR; Murphy SB; Camitta BM; Amylon MD
    Leukemia; 2000 May; 14(5):792-5. PubMed ID: 10803508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different patterns of relapse associated with three intensive treatment regimens for pediatric E-rosette positive T-cell leukemia: a Pediatric Oncology Group study.
    Falletta JM; Shuster JJ; Crist WM; Pullen DJ; Borowitz MJ; Wharam M; Patterson R; Foreman E; Vietti TJ
    Leukemia; 1992 Jun; 6(6):541-6. PubMed ID: 1602793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
    Steinherz PG; Gaynon PS; Breneman JC; Cherlow JM; Grossman NJ; Kersey JH; Johnstone HS; Sather HN; Trigg ME; Uckun FM; Bleyer WA
    Cancer; 1998 Feb; 82(3):600-12. PubMed ID: 9452280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acute lymphoblastic leukaemia (ALL).
    Jacobs P; Wood L
    Eur J Haematol; 1992 Aug; 49(2):53-8. PubMed ID: 1397240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
    Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
    Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.
    Atra A; Gerrard M; Hobson R; Imeson JD; Ashley S; Pinkerton CR
    Br J Cancer; 1998 Jun; 77(12):2281-5. PubMed ID: 9649146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.
    Mantadakis E; Danilatou V; Stiakaki E; Paterakis G; Papadhimitriou S; Kalmanti M
    Pediatr Blood Cancer; 2007 Mar; 48(3):354-7. PubMed ID: 16206214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A classification based on T cell selection-related phenotypes identifies a subgroup of childhood T-ALL with favorable outcome in the COALL studies.
    Niehues T; Kapaun P; Harms DO; Burdach S; Kramm C; Körholz D; Janka-Schaub G; Göbel U
    Leukemia; 1999 Apr; 13(4):614-7. PubMed ID: 10214870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug resistance (MDR-1) expression in AIDS-related lymphomas.
    Tulpule A; Sherrod A; Dharmapala D; Young LL; Espina BM; Sanchez MN; Gill PS; Levine AM
    Leuk Res; 2002 Feb; 26(2):121-7. PubMed ID: 11755462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.
    Mottl H; Bajciova V; Nemec J; Al Shemmari S; Al Awadi S
    Pediatr Hematol Oncol; 2003 Mar; 20(2):103-10. PubMed ID: 12554521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.
    Grenzebach J; Schrappe M; Ludwig WD; Parwaresch R; Zimmermann M; Gadner H; Riehm H; Reiter A;
    Ann Hematol; 2001; 80 Suppl 3():B73-6. PubMed ID: 11757713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood. COALL study group].
    Janka-Schaub GE; Stührk H; Kortüm B; Graubner U; Jürgens H; Spaar HJ; Schöck V; Dohrn B; Bahr R; Winkler K
    Klin Padiatr; 1991; 203(4):231-5. PubMed ID: 1942930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment results of T-cell acute lymphoblastic leukemia therapy in children from 1983-1985].
    Kubiczek K; Rytlewska M; Pituch-Noworolska A
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):273-5. PubMed ID: 7808950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of adult acute lymphoblastic leukaemia.
    Jacobs P; Wood L; Novitzky N
    Haematol Blood Transfus; 1990; 33():428-31. PubMed ID: 2323650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of two regimens for high-risk acute lymphocytic leukemia in childhood. A Pediatric Oncology Group Study.
    van Eys J; Berry D; Crist W; Doering E; Fernbach D; Pullen J; Shuster J; Wharam M
    Cancer; 1989 Jan; 63(1):23-9. PubMed ID: 2910421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.